Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), sold 323 shares at $1.82 ($588) on 2026-02-03, disclosed to the SEC on 2026-02-05.
Seasonal sale ($588) by SVP Finance & Operations — this insider has traded IPSC in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| IPSC | SELL | 2026-06-15 | $4K | — | Filing → |
| IPSC | SELL | 2026-06-09 | $526 | — | Filing → |
| IPSC | SELL | 2026-05-06 | $618 | — | Filing → |